Transitioning from multiple daily injections to a tubeless automated insulin delivery (AID) system significantly improves HbA1c in T1D.
Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results